Site Search
Professionals 411 results
Capabilities 73 results
Practice Area
Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing.
Europe
The transactional lawyers based in our London, Paris, and Brussels offices are seasoned practitioners with decades of experience advising on complex cross-border transactions. The long-established relationships we have cultivated with local counsel in countries across the continent, combined with our experience and demonstrated track record, makes us one of the go-to firms for cross-border corporate and finance transactions in Europe.
Practice Area
Representation & Warranty Insurance Claims
Winston is a market leader in the field of representation and warranty insurance (RWI) claims. With an in-depth understanding of the complexities and nuances of contractual agreements, we are skilled at meticulously analyzing purchase agreements, identifying potential breaches, and formulating comprehensive recovery strategies. This enables us to deliver favorable outcomes for our clients, making us a go-to-choice for buyers seeking preeminent counsel in this nuanced area of law.
Experience 466 results
Experience
|July 15, 2025
Atsion Commits Up to $200 Million in Strategic OFA Investment
Experience
|July 15, 2025
Winston Represented Cuadrilla Capital in the Acquisition of TigerGraph
Experience
|June 25, 2025
Winston Secures Federal Circuit Affirmance of 101 Victory for Polycom
Insights & News 7,741 results
Seminar/CLE
|January 22, 2026
14th ITA-IEL-ICC Joint Conference on International Energy Arbitration – Houston
Imad Khan is a proud Co-Chair of The Institute for Transnational Arbitration (ITA), Institute for Energy Law (IEL) and International Chamber of Commerce (ICC) International Court of Arbitration 14th edition of what has become the premier conference on international arbitration in the energy sector. Speakers from around the globe and across the industry will gather to focus on the key issues in the field today.
Sponsorship
|September 18, 2025
Winston & Strawn Sponsors 21st Annual Boardroom Summit
Winston & Strawn is sponsoring the upcoming 21stAnnual Boardroom Summit & Board Committee Peer Exchange. This unique event will bring industry leading public company directors to discuss current trends, including shareholder activism, CEO succession strategies, and uses of AI in the boardroom.
Sponsorship
|September 18, 2025
Winston Sponsors New York Office Leasing & Asset Management Conference
Winston is proud to sponsor the upcoming New York Office Leasing & Asset Management Conference. This event will discuss actionable strategies in the evolving New York City commercial landscape as well as leasing trends, asset upgrades, and key submarkets driving demand.
Other Results 148 results
Law Glossary
What Is the Difference Between a Biosimilar and a Generic Drug?
A biosimilar is a biologic product that—as the name implies—is similar to its reference product. Because of a biologic’s complexity, it is not possible to synthesize identical biosimilars that are identical copies of their associated reference products.
Law Glossary
What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?
There are fundamental differences between the abbreviated approval processes to obtain FDA approval for biosimilars and generic drugs as those processes relate to patent litigation.
Site Content
Emerging technology is a term generally used to describe a new technology, but it may also refer to the continuing development of an existing technology; it can have slightly different meaning when used in different areas, such as media, business, science, or education. The term commonly refers to technologies that are currently developing, or that are expected to be available within the next five to ten years, and is usually reserved for technologies that are creating, or are expected to create, significant social or economic effects.